About: http://linked.opendata.cz/resource/sukl/spc/sentence/SPC156352

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://linked.opendata.cz/resource/sukl/spc/sentence/SPC156352_doc-4-8-151-1 Goto Sponge NotDistinct Permalink

An Entity of Type : salt:Sentence, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	salt:Sentence
salt:hasEndPointer	24009 (xsd:long)
salt:hasTextChunk	http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23261-23271 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23279-23289 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23295-23305 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23331-23341 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23353-23363 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23369-23379 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23452-23458 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23672-23677 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23716-23722 http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156352_doc-4-8-151-1-23619-23639
salt:hasStartPointer	23231 (xsd:long)
salt:hasOrderNumber	1 (xsd:int)
salt:hasText	Nežádoucí účinky stupně 3 a 4 Paklitaxel versus gemcitabin plus paklitaxel Počet (%) pacientů Paklitaxel (N = 259) Gemcitabin plus paklitaxel (N=262) Stupeň 3 Stupeň 4 Stupeň 3 Stupeň 4 Laboratorní Anémie 5 (1,9) 1 (0,4) 15 (5,7) 3 (1,1) Trombocytopenie 0 0 14 (5,3) 1 (0,4) Neutropenie 11 (4,2) 17 (6,6)* 82 (31,3) 45 (17,2)* Nelaboratorní Febrilní neutropenie 3 (1,2) 0 12 (4,6) 1 (0,4) Únava 3 (1,2) 1 (0,4) 15 (5,7) 2 (0,8) Průjem 5 (1,9) 0 8 (3,1) 0 Motorická neuropatie 2 (0,8) 0 6 (2,3) 1 (0,4) Senzorická neuropatie 9 (3,5) 0 14 (5,3) 1 (0,4) *Neutropenie stupně 4 trvající déle než 7 dnů se projevila u 12,6 % pacientů ve skupině kombinované léčby a u 5 % pacientů ve skupině samotného paklitaxelu. (cs)
is salt:hasSentence of	http://linked.opendata.cz/resource/sukl/spc/paragraph/SPC156352_doc-4-8-151

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 110 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software